Pamiparib + Temozolomide
Sources
registry, as of 2026-11-07
https://clinicaltrials.gov/api/v2/studies?query.cond=glioma&query.term=IDH
ClinicalTrials.gov API v2: IDH-mutant glioma interventional records plus 34 individual records, retrieved 11.07.2026 (registry fields as entered by sponsors)
Brief source I16
registry, as of 2026-11-07
https://clinicaltrials.gov/study/NCT03749187
A Target Validation/Phase1 Study of BGB-290 in Combination With Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
ClinicalTrials.gov API v2 record, retrieved 2026-11-07